Literature DB >> 589880

Serum procainamide levels as therapeutic guides.

J Koch-Weser.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 589880     DOI： 10.2165/00003088-197702060-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  73 in total

1.  Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.

Authors:  C Graffner
Journal:  J Pharmacokinet Biopharm       Date:  1975-04

2.  Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.

Authors:  B F Hoffman; M R Rosen; A L Wit
Journal:  Am Heart J       Date:  1975-06       Impact factor: 4.749

3.  Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.

Authors:  S G Dahl; D Fremstad; S Jacobsen; I Kvaleid; K H Landmark; P K Lunde; A A Marthinsen; K J Nådland; T Waaler
Journal:  Pharm Acta Helv       Date:  1976

4.  Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.

Authors:  M Arstila; M Katila; H Sundquist; M Anttila; E Pere; R Tikkanen
Journal:  Acta Med Scand       Date:  1974-03

5.  Pacemaker failure due to procainamide toxicity.

Authors:  R J Gay; D F Brown
Journal:  Am J Cardiol       Date:  1974-11       Impact factor: 2.778

6.  Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors:  J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal:  N Engl J Med       Date:  1969-12-04       Impact factor: 91.245

7.  Pharmacokinetics of procainamide.

Authors:  H S Weily; E Genton
Journal:  Arch Intern Med       Date:  1972-09

Review 8.  Pharmacologic and clinical control of antiarrhythmic drugs.

Authors:  J T Bigger
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

9.  Hemodialysis for severe procainamide toxicity: clinical and pharmacokinetic observations.

Authors:  A J Atkinson; F A Krumlovsky; C M Huang; F del Greco
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

10.  Comparison of the acetylation of procainamide and sulfadimidine in man.

Authors:  K Frislid; M Berg; V Hansteen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953
View more
  12 in total

1.  Pharmacokinetic variability and therapeutic drug monitoring actions at steady state.

Authors:  M Ramanathan
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

2.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 3.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 4.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

5.  Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Authors:  J L Anderson; D C Harrison; P J Meffin; R A Winkle
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

6.  Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.

Authors:  U Klotz; P Müller-Seydlitz; P Heimburg
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of procainamide.

Authors:  E Karlsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

8.  Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.

Authors:  A Somogyi; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

9.  Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.

Authors:  P Ylitalo; R Ruosteenoja; O Leskinen; T Metsä-Ketelä
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.

Authors:  A Somogyi; A McLean; B Heinzow
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.